LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

Long interspersed element 1 (LINE-1) open reading frame 1 protein (ORF1p) expression is a common feature of many cancer types, including high-grade serous ovarian carcinoma (HGSOC). Here, we report that ORF1p is not only expressed but also released by ovarian cancer and primary tumor cells. Immuno-m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2023-01, Vol.13 (1), p.1537-1537, Article 1537
Hauptverfasser: Sato, Sho, Gillette, Michael, de Santiago, Pamela R., Kuhn, Eric, Burgess, Michael, Doucette, Kristen, Feng, Yi, Mendez-Dorantes, Carlos, Ippoliti, Paul J., Hobday, Sara, Mitchell, Marilyn A., Doberstein, Kai, Gysler, Stefan M., Hirsch, Michelle S., Schwartz, Lauren, Birrer, Michael J., Skates, Steven J., Burns, Kathleen H., Carr, Steven A., Drapkin, Ronny
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Long interspersed element 1 (LINE-1) open reading frame 1 protein (ORF1p) expression is a common feature of many cancer types, including high-grade serous ovarian carcinoma (HGSOC). Here, we report that ORF1p is not only expressed but also released by ovarian cancer and primary tumor cells. Immuno-multiple reaction monitoring-mass spectrometry assays showed that released ORF1p is confidently detectable in conditioned media, ascites, and patients’ plasma, implicating ORF1p as a potential biomarker. Interestingly, ORF1p expression is detectable in fallopian tube (FT) epithelial precursors of HGSOC but not in benign FT, suggesting that ORF1p expression in an early event in HGSOC development. Finally, treatment of FT cells with DNA methyltransferase inhibitors led to robust expression and release of ORF1p, validating the regulatory role of DNA methylation in LINE-1 repression in non-tumorigenic tissue.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-28840-5